Stock Fundamentals

CTXR.US Logo

CTXR.US - Current Price

$1.14

Company Information

▼
Company Name
Citius Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US17322U2078
CIK: 0001506251
CUSIP: 17322U207
Currency: USD
Full Time Employees: 23
Phone: 908 967 6677
Website: https://citiuspharma.com
Fiscal Year End: September
IPO Date: Jul 06, 2017
Description:

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Address:

11 Commerce Drive, Cranford, NJ, United States, 07016

Directors & Officers

▼
Name Title Year Born
Mr. Leonard L. Mazur Co-Founder, CEO, Chairman & Secretary 1945
Mr. Myron Z. Holubiak Co-Founder & Executive Vice Chairman 1947
Mr. Jaime Bartushak Chief Business Officer & CFO 1968
Mr. Gary F. Talarico Executive Vice President of Operations 1955
Ms. Ilanit Allen Vice President of Investor Relations & Corporate Communications NA
Dr. Alan Lader Ph.D. Senior VP and Head of Clinical Operations & Quality Assurance NA
Dr. Myron S. Czuczman M.D. Executive VP & Chief Medical Officer 1960
Mr. Dhananjay G. Wadekar Senior Vice President of Business Strategy 1954
Mr. Kelly Creighton Ph.D. Executive Vice President of Chemistry, Manufacturing & Controls NA
Mr. Nikolas Burlew Executive Vice President of Quality Assurance NA

Shares Statistics

▼
Shares Outstanding: 18.47M
Shares Float: 15.21M
% Insiders: 309.30%
% Institutions: 1,308.10%
Short % Float: 14.35%

Valuation Metrics

▼
Enterprise Value: $14.45M
Trailing P/E: 0.00
Forward P/E: 2.73

Financial Highlights

▼
Market Cap: $21.06M
EBITDA: $-41.14M
PEG Ratio: $0.00
Book Value: $4.50
Earnings/Share: $-4.87
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -22.88%
ROE (TTM): -54.70%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Jun 30, 2025 -0.80 0.05 N/A -170,000.00%
Mar 31, 2025 -1.27 0.11 N/A -125,454.55%
Dec 31, 2024 -1.30 -1.25 N/A -400.00%
Sep 30, 2024 -1.59 -0.04 N/A -387,250.00%
Jun 30, 2024 -0.06 -0.05 N/A -2,000.00%
Mar 31, 2024 -0.05 -0.06 N/A 1,666.67%
Dec 31, 2023 -0.06 0.13 N/A -14,615.38%
Sep 30, 2023 -0.08 -0.02 N/A -30,000.00%
Jun 30, 2023 -0.06 -0.05 N/A -2,000.00%
Mar 31, 2023 -0.07 -0.04 N/A -7,500.00%
Dec 31, 2022 -0.02 -0.06 N/A 6,666.67%
Sep 30, 2022 -0.05 -0.04 N/A -2,500.00%
Jun 30, 2022 -0.06 -0.05 N/A -2,000.00%
Mar 31, 2022 -0.05 -0.07 N/A 2,857.14%
Dec 31, 2021 -0.06 -0.06 N/A 0.00%
Sep 30, 2021 -0.02 -0.04 N/A 5,000.00%
Jun 30, 2021 -0.06 -0.06 N/A 0.00%
Mar 31, 2021 -0.04 -0.07 N/A 4,285.71%
Dec 31, 2020 -0.15 0.16 N/A -19,375.00%
Sep 30, 2020 -0.07 -0.10 N/A 3,000.00%
Jun 30, 2020 -0.11 -0.10 N/A -1,000.00%
Mar 31, 2020 -0.13 -0.10 N/A -3,000.00%
Dec 31, 2019 -0.15 -0.14 N/A -714.29%
Sep 30, 2019 -0.16 -0.14 N/A -1,428.57%
Jun 30, 2019 -0.20 -0.20 N/A 0.00%
Mar 31, 2019 -0.20 -0.20 N/A 0.00%
Dec 31, 2018 -0.22 -0.21 N/A -476.19%
Sep 30, 2018 -0.16 -0.16 N/A 0.00%
Jun 30, 2018 -0.19 -0.32 N/A 4,062.50%
Mar 31, 2018 -0.44 N/A N/A N/A
Dec 31, 2017 -0.38 N/A N/A N/A
Sep 30, 2017 -0.43 N/A N/A N/A
Jun 30, 2017 -0.49 N/A N/A N/A
Mar 31, 2017 -0.55 N/A N/A N/A
Dec 31, 2016 -11.09 N/A N/A N/A
Sep 30, 2016 -13.28 N/A N/A N/A
Jun 30, 2016 -18.66 N/A N/A N/A
Mar 31, 2016 -8.75 N/A N/A N/A
Dec 31, 2015 -13.30 N/A N/A N/A
Sep 30, 2015 -9.98 N/A N/A N/A
Jun 30, 2015 -9.57 N/A N/A N/A
Mar 31, 2015 -4.16 N/A N/A N/A
Dec 31, 2014 -10.28 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-09-30 $3.25M $N/A $116.65M $42.55M $70.08M
2023-09-30 $26.48M $N/A $103.61M $12.18M $90.83M
2022-09-30 $41.71M $N/A $114.00M $10.57M $102.83M
2021-09-30 $70.07M $N/A $142.43M $9.65M $132.18M
2020-09-30 $13.86M $N/A $43.77M $10.10M $33.67M
2019-09-30 $7.89M $N/A $28.99M $4.61M $24.38M
2018-09-30 $9.18M $N/A $31.05M $3.18M $27.87M
2017-09-30 $3.20M $N/A $24.42M $2.47M $21.95M
2016-09-30 $294.35K $N/A $21.95M $5.18M $16.77M
2015-09-30 $676.14K $N/A $741.54K $1.38M $-635.21K
2014-09-30 $1.55M $N/A $1.56M $2.30M $-741.94K
2013-09-30 $54.39K $N/A $107.97K $14.69K $-14.69K
2012-09-30 $135.00 $N/A $135.00 $45.98K $-45.85K
2011-09-30 $212.00 $N/A $212.00 $24.05K $-23.84K

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 27, 2019 N/A N/A N/A N/A N/A N/A
Sep 27, 2019 N/A N/A N/A N/A N/A N/A
Sep 25, 2019 N/A N/A N/A N/A N/A N/A
Apr 03, 2019 N/A N/A N/A N/A N/A N/A
Apr 03, 2019 N/A N/A N/A N/A N/A N/A
Aug 13, 2018 N/A N/A N/A N/A N/A N/A
Mar 28, 2018 N/A N/A N/A N/A N/A N/A
Aug 24, 2017 N/A N/A N/A N/A N/A N/A
Aug 08, 2017 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist